Nidaria Technology

Nidaria Technology is an Israeli biotechnology company that specializes in the development and manufacture of marine-inspired skincare and sun protection products. The company is internationally recognized for its patented "Safe Sea" technology, which provides the world's first dual-protection formula against both jellyfish stings and UV radiation. Their innovative biochemical mechanism mimics the natural defense of the clownfish by using chemical inhibitors to block the triggers and pressure-firing mechanisms of jellyfish nematocysts (stinging cells). Clinically validated by institutions such as Stanford University Hospital, the company's products are distributed globally and meet rigorous FDA, EU, and Japanese regulatory standards. Nidaria operates its own R&D laboratories and GMP-compliant manufacturing facilities, also providing contract manufacturing services for major international cosmetic and pharmaceutical brands.